['(5Z)-7-Oxozeaenol', '/screening-compounds/349381', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/oxozeaenol_5.jpg', 'C19H22O7', '362.37', 'TAK1', 'Ninomiya-Tsuji (2003)  J.Biol.Chem. 278 18485', 'Windheim et al (2007) Biochem.J. 404 179']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/oxozeaenol_5.jpg  C19H22O7
['1 NA-PP1 (PP1 Analog)', '/screening-compounds/341022', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/1-na-pp1_0.jpg', 'C19H19N5', '317.4', 'Src', 'Bishop A. C. (2000) Nature 407 395', 'Bishop A.C. (1999) J. Am. Chem. Soc. 121 627']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/1-na-pp1_0.jpg  C19H19N5
['1 NM-PP1 (PP1 Analog II)', '/screening-compounds/341023', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/1-nm-pp1_2.jpg', 'C20H21N5', '331.4', 'Src', 'Ira G.  (2004) Nature 431 1011', 'Papa F.R. (2003) Science 302 1533']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/1-nm-pp1_2.jpg  C20H21N5
['2-Aminopurine', '/screening-compounds/589960', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/2-aminopurine.jpg', 'C5H5N5', '135.1267', 'PKR']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/2-aminopurine.jpg  C5H5N5
['A-443654', '/screening-compounds/341024', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/a-443654_0.jpg', 'C24H23ON5x2HCl', '470.39', 'Akt1', 'Shi Y. (2005) Neoplasia 7 992-1000.']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/a-443654_0.jpg  C24H23ON5x2HCl
['A-769662', '/screening-compounds/341025', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/a-769662_4.jpg', 'C20H12N2O3S', '360.39', 'AMPK Activator', 'Cool B. (2006) Cell Metabolism 3 403-416']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/a-769662_4.jpg  C20H12N2O3S
['A-83-01', '/screening-compounds/348823', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/a-83-01_5.jpg', 'C25H19N5S', '421.52', 'ALK5', 'Tojo (2005)  Cancer.Sci. 96 791']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/a-83-01_5.jpg  C25H19N5S
['ADP-D-b-D-Hep', '/screening-compounds/698628', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/377.jpg', 'C17H33N7O16P2', '653.43', 'activator ALPK1']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/377.jpg  C17H33N7O16P2
['ADP-L-b-D-Hep', '/screening-compounds/698629', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/378.jpg', 'C17H33N7O16P2', '653.43', 'activator ALPK1']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/378.jpg  C17H33N7O16P2
['AG1296 (Tyrphostin)', '/screening-compounds/348805', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ag-1296_5.jpg', 'C16H14N2O2', '266.29', 'PDGF', 'Kovalenko M. (1994) Cancer Res. 54 6106']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ag-1296_5.jpg  C16H14N2O2
['AG1478 (Tyrphostin)', '/screening-compounds/348815', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ag-1478_4.jpg', 'C16H14ClN3O2', '315.75', 'EGFR', 'Osherov N. (1994) A. Eur. J. Biochem. 225 1047']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ag-1478_4.jpg  C16H14ClN3O2
['AG490', '/screening-compounds/341026', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ag-490_2.jpg', 'C17H14N2O3', '294.3', 'EGFR, JAK', 'Jaleel M.  (2004) Biochemistry 43 8247', 'Eriksen K.W. (2001) Leukemia 15 787']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ag-490_2.jpg  C17H14N2O3
['AG879 (Tyrphostin)', '/screening-compounds/341027', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ag-879_4.jpg', 'C18H24N2OS', '316.5', 'Tyrosine-kinases', 'Konrad R.J.  (1996) J. Biol. Chem. 271 24179', 'Levitzki A. Gazit A. (1995) Science 267 1782']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ag-879_4.jpg  C18H24N2OS
['Akt Inhibitor IV', '/screening-compounds/348809', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/akt-inhibitor-iv_5.jpg', 'C31H27IN4S', '614.6', 'Akt', 'Kau T. R. (2003) Cancer Cell 4 463']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/akt-inhibitor-iv_5.jpg  C31H27IN4S
['Akti 1/2', '/screening-compounds/341028', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/akti-1-2_4.jpg', 'C34H29N7O', '551.6', 'Akt1, Akt2', 'Logie L. (2007) Diabetes 2218-27', 'Barnett S.F. (2005) Biochem. J. 385 399']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/akti-1-2_4.jpg  C34H29N7O
['Alsterpaullone', '/screening-compounds/341029', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/alsterpaullone_4.jpg', 'C16H11N3O3', '293.3', 'GSK3b, CDK5/p25, CDK1/cyclin B', 'Leost M.  (2000) Eur. J. Biochem. 267 5983', 'Schultz C. (1999) J. Med. Chem. 42 2909']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/alsterpaullone_4.jpg  C16H11N3O3
['Amgen TBK 1 inhibitor (Compound II)', '/screening-compounds/349410', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/amgen-tbk1-inhibitor_6.jpg', 'C28H35N7O4', '533.62', 'TBK1', 'Ou Y.H. (2011) Molecular Cell 41 458-470']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/amgen-tbk1-inhibitor_6.jpg  C28H35N7O4
['Amgen-NIK-28', '/screening-compounds/594366', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/Amgen-NIK-28.jpg', 'C20H20N4O', '332.4', 'NIK', 'Li K. (2013) Bioorganic and Medicinal Chemistry Letters 23 1238-1244']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/Amgen-NIK-28.jpg  C20H20N4O
['Amlexanox', '/screening-compounds/594370', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/Amlexanox.jpg', 'C16H14N2O4', '298.293', 'TBK1, IKKe']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/Amlexanox.jpg  C16H14N2O4
['ARA014418', '/screening-compounds/341030', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ara014418_4.jpg', 'C12H12N4O4S', '308.3', 'GSK3', 'Noble W.  (2005) Proc. Natl. Acad. Sci. USA 102 6990', 'Bhat R. (2003) J. Biol. Chem. 278 45937']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ara014418_4.jpg  C12H12N4O4S
['AS601245 (JNK Inhibitor V)', '/screening-compounds/341031', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/as601245_4.jpg', 'C20H16N6S', '372.5', 'JNK', 'Gaillard P.  (2005) J. Med. Chem. 48 4596', 'Carboni S. (2005) J. Neurochem. 92 1054']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/as601245_4.jpg  C20H16N6S
['AX 20017', '/screening-compounds/349385', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ax-20017_6.jpg', 'C13H16N2O2S', '264.34', 'PknG', 'Walburger A (2004) Science 304 1800-1804']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ax-20017_6.jpg  C13H16N2O2S
['AZD8055', '/screening-compounds/349404', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/azd8055_5.jpg', 'C25H31N5O4', '465.5', 'mTOR C1, mTOR C2', 'Chresta C.M. (2010) Cancer Res. 70 288-298', 'Sini P. (2010) Autophagy 6(4)']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/azd8055_5.jpg  C25H31N5O4
['BAY 61-3606', '/screening-compounds/340806', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bay-61-3606_0.jpg', 'C20H18N6O3 · xHCl · yH2O', '390.40', 'Syk', 'Yamamoto N. (2003) J. Pharmacol. Exp. Ther. 306 1174-1181']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bay-61-3606_0.jpg  C20H18N6O3 · xHCl · yH2O
['Bay 65-1942', '/screening-compounds/341032', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bay-65-1942_4.jpg', 'C22H26ClN3O4', '431.91', 'IKKb', 'Ziegelbauer K. (2005) British Journal of Pharmacology 145 178-192 (compound A)', 'Moss N.C. (2007) Am J Physiol Heart Circ Physiol 293 H2248-53']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bay-65-1942_4.jpg  C22H26ClN3O4
['BAY-11-7082', '/screening-compounds/341033', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bay-11-7082_4.jpg', 'C10H9NO2S', '207.2', 'NFKBIA', 'Kamthong P.J. (2001) Biochem. J. 356', 'Izban K.F. (2000) Hum. Pathol. 31 1482']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bay-11-7082_4.jpg  C10H9NO2S
['BAY439006 (Sorafenib, Nexavar)', '/screening-compounds/341034', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bay-43-9006_4.jpg', 'C21H16ClF3N4O3', '464.8', 'Raf, Multiple Tyrosine Kinases Targeted', 'Lyons J.F. (2001) Endocrine Related Cancer 8 3 219-225', 'Wilhelm S.M. (2004) Cancer Res. 64(19) 7099-109']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bay-43-9006_4.jpg  C21H16ClF3N4O3
['BI 2536', '/screening-compounds/341035', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bi-2563_2.jpg', 'C28H39N7O3', '521.65', 'PLK1', 'Steegmaier M. (2007) Current Biology 17 316-322']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bi-2563_2.jpg  C28H39N7O3
['BI-78D3', '/screening-compounds/348793', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bi-78d3_5.jpg', 'C13H9N5O5S2', '379.37', 'JNK', 'Stebbins J.L. (2008) PNAS 105 16809-16813']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bi-78d3_5.jpg  C13H9N5O5S2
['BI-D-1870', '/screening-compounds/341036', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bi-d-1870_4.jpg', 'C19H23N5O2F2', '391.42', 'RSK', 'Sapkota G.P.  (2007) Biochem. J. 401 29–38']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bi-d-1870_4.jpg  C19H23N5O2F2
['BI605906 (BIX02514)', '/screening-compounds/334622', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bi605906_3.jpg', 'C17H22F2N4O3S2', '432.51', 'IKKβ', 'Clark K. (2011) Biochem. J. 434 93-104']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bi605906_3.jpg  C17H22F2N4O3S2
["BIO (6-Bromoindirubin-3'-oxime)", '/screening-compounds/341037', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bio_4.jpg', 'C16H10BrN3O2', '356.2', 'GSK3', 'Tseng A.S.  (2006) Chem. Biol. 13 957', 'Polychronopoulos P. (2004) J. Med. Chem. 47 935']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bio_4.jpg  C16H10BrN3O2
['BIRB-0796 (Doramapimod)', '/screening-compounds/341038', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/birb-0796_4.jpg', 'C31H37N5O3', '527.66', 'p38 MAPK', 'Regan J. (2002) J. Med. Chem 45 2994-3008']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/birb-0796_4.jpg  C31H37N5O3
['Blebbistatin', '/screening-compounds/341039', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/blebbistatin_4.jpg', 'C18H16N2O2', '292.3', 'myosin II', 'Shu S. (2005) Proc. Natl. Acad. Sci. USA 102 1472', 'Kovacs M. (2004) J. Biol. Chem. 279 35557']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/blebbistatin_4.jpg  C18H16N2O2
['BML-258 (SK1-I)', '/screening-compounds/349380', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bml-258_5.jpg', 'C17H28ClNO2', '313.86', 'SphK1', 'Paugh S.W. (2008) Blood  112 1382-1391']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bml-258_5.jpg  C17H28ClNO2
['BMS345541 (IKK Inhibitor III)', '/screening-compounds/341040', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bms345541_4.jpg', 'C14H17N5', '255.32', 'IKBKB', 'Du Z. (2012) J Interferon Cytokine Res. 368-77']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bms345541_4.jpg  C14H17N5
['BTX 161', '/screening-compounds/698624', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/373.jpg', 'C15H16N2O3', '272.3', 'CK1a-PHM inhibitor']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/373.jpg  C15H16N2O3
['BX-320', '/screening-compounds/341041', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bx-320_4.jpg', 'C23H31BrN8O3', '547.45', 'PDK1', 'Feldman R.I. (2005) Journal of Biological Chemistry 280 19867-19874']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bx-320_4.jpg  C23H31BrN8O3
['BX-517', '/screening-compounds/341042', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bx-517_4.jpg', 'C15H14N4O2', '282.3', 'PDK1', 'Islam I. (2007) Bioorganic and Medicinal Chemistry Letters 17 3814-3818']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bx-517_4.jpg  C15H14N4O2
['BX-517 Analog (compound 7b)', '/screening-compounds/341043', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bx-517-analogue_4.jpg', 'C19H15N5O2', '345.35', 'PDK1', 'Islam I. (2007) Bioorganic and Medicinal Chemistry Letters 17 3819-3825']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bx-517-analogue_4.jpg  C19H15N5O2
['BX-795', '/screening-compounds/341044', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bx-795_4.jpg', 'C23H26IN7O2S', '591.47', 'PDK1', 'Feldman R.I. (2005) Journal of Biological Chemistry 280 19867-19874']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/bx-795_4.jpg  C23H26IN7O2S
['BX-912', '/screening-compounds/600888', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/BX-912.jpg', 'C20H23BrN8O', '471.35', 'PDK', 'Feldman RI. (2005) J. Biol. Chem. 2005 May 20 280(20) 19867-74']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/BX-912.jpg  C20H23BrN8O
['Caffeine', '/screening-compounds/348797', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/caffeine_5.jpg', 'C8H10N4O2', '194.19', 'ATM', 'Islam M.S. (1998) Proc. Natl. Acad. Sci. USA 95 6145-6150']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/caffeine_5.jpg  C8H10N4O2
['CAY10576', '/screening-compounds/594371', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/CAY10576.jpg', 'C22H19N3O5S2', '469.5', 'IKKe']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/CAY10576.jpg  C22H19N3O5S2
['CCT250862', '/screening-compounds/340811', 'NEK']
['CCT250862', '/screening-compounds/340811', 'NEK']

['Celastrol', '/screening-compounds/601587', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/Celestrol.jpg', 'C29H38O4', '450.6', 'hsp90, ampk', 'Kim JH. Cell Signal. (2013) 805-13']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/Celestrol.jpg  C29H38O4
['CGP-57380', '/screening-compounds/341046', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/cgp-57380_4.jpg', 'C11H9FN6', '244.23', 'MNK', 'Knauf U. (2001) Mol. Cell. Biol. 21 5500-5511', 'Proud C.G. (2005) Immunity 23 177-189']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/cgp-57380_4.jpg  C11H9FN6
['CGP-57380 analog (SHN-093)', '/screening-compounds/341047', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/cgp-57380-analogue-1_4.jpg', 'C12H11FN6', '258.25', 'MNK', 'Proud C.G. (2005) Immunity 23 177-189']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/cgp-57380-analogue-1_4.jpg  C12H11FN6
['CGP-57380 analog (SHN-095)', '/screening-compounds/341048', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/cgp-57380-analogue-2_3.jpg', 'C13H14N6', '254.29', 'MNK']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/cgp-57380-analogue-2_3.jpg  C13H14N6
['Chelerythrine Chloride', '/screening-compounds/341049', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/chelerythrine_3.jpg', 'C21H18NO4Cl', '383.8', 'PKC', 'Kandasamy R.A.  (1995) J. Biol. Chem. 270 29209', 'Jarvis W.D. (1994) Cancer Res. 54 1707']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/chelerythrine_3.jpg  C21H18NO4Cl
['CHIR 99021 (CT 99021)', '/screening-compounds/341051', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/chir-99021_3.jpg', 'C22H18Cl2N8', '465.34', 'GSK3', 'Ring D.B. (2003) Diabetes 52 588']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/chir-99021_3.jpg  C22H18Cl2N8
['Chloroquine', '/screening-compounds/591458', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/Chloroquine.jpg', 'C18H26ClN3', '319.87214', 'Anti Malarial']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/Chloroquine.jpg  C18H26ClN3
['CKI-7', '/screening-compounds/341052', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ck1-7_4.jpg', 'C11H12ClN3O2S • 2HCl', '358.67', 'CK1', 'Rena G. (2004) EMBO Rep. 5 60-65']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ck1-7_4.jpg  C11H12ClN3O2S • 2HCl
['Compound C (Dorsomorphin)', '/screening-compounds/341053', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/compound-c_3.jpg', 'C24H25N5O', '399.5', 'AMPK', 'Yu P.B.  (2008) Nat. Chem. Biol. 4 33', 'Kim E.K. (2004) J. Biol. Chem. 279 19970']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/compound-c_3.jpg  C24H25N5O
['Cot-Tpl2 Inhibitor Compound 10b (Abbott)', '/screening-compounds/334620', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/cot-tpl2-compound-10b_0.jpg', 'C20H15N3OS', '345.42', 'Cot-Tpl2', 'Cusack K. (2009) Bioorganic and MedicinalChemistry Letters 19 1722-1725']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/cot-tpl2-compound-10b_0.jpg  C20H15N3OS
['Cot-Tpl2 Inhibitor Compound 38 (Abbott)', '/screening-compounds/348799', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/cot-tpl2-compound-38_3.jpg', 'C21H12F3N5OS', '439.41', 'Cot-Tpl2', 'George D. Friedman M. (2008) Bioorganic and Medicinal Chemistry Letters  18 4952-4955']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/cot-tpl2-compound-38_3.jpg  C21H12F3N5OS
['Cot-Tpl2 Inhibitor Compound 41 (Abbott)', '/screening-compounds/348796', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/cot-tpl2-compound-41_5.jpg', 'C21H14N6O2S', '414.44', 'Cot-Tpl2', 'George D. Friedman M. (2008) Bioorganic and Medicinal Chemistry Letters  18 4952-4955']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/cot-tpl2-compound-41_5.jpg  C21H14N6O2S
['CP-690550 (Tasocitinib)', '/screening-compounds/349397', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/cp-690550_6.jpg', 'C16H20N6O', '312.38', 'JAKs', 'Manshouri T. (2008) Cancer Sci. 99(6) 1265-73']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/cp-690550_6.jpg  C16H20N6O
['Crenolanib', '/screening-compounds/608461', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/crenolanib.jpg', 'C26H29N5O2', '443.5', 'FLT3', 'Smith CC (2014 )Proc Natl Acad Sci U S A Apr 8 111(14) 5319-24']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/crenolanib.jpg  C26H29N5O2
['Curcumin', '/screening-compounds/341054', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/curcumin_4.jpg', 'C21H20O6', '368.4', 'Inhibits EGF receptor', 'Cui L.  (2007) Antimicrob. Agents Chemother. 51 488', 'Salvioli S. (2007) eCAM 4 181']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/curcumin_4.jpg  C21H20O6
['CZC-25146', '/screening-compounds/349413', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/czc-25146_5.jpg', 'C22H25FN6O4S', '488.54', 'LRRK2', 'Ramsden N. (2011) ASC Chemical Biology']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/czc-25146_5.jpg  C22H25FN6O4S
['D 4476', '/screening-compounds/341055', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/d-4476_4.jpg', 'C23H18N4O3', '398.41', 'CK1', 'Liverton N.J. (1999) J. Med. Chem 42 2180-2190']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/d-4476_4.jpg  C23H18N4O3
['Dasatinib', '/screening-compounds/601588', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/Dasatinib.jpg', 'C22H26ClN7O2S', '487', 'BCR-ABL, Src, Multiple Tyrosine kinases targeted', 'Kantarjian H. N Engl J Med. (2010) 2260-70']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/Dasatinib.jpg  C22H26ClN7O2S
['Dimethyl fumarate', '/screening-compounds/340807', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/dimethyl-fumarate_3.jpg', 'C6H8O4', '144.13', 'Peng H. (2112) J Biol Chem. 287(33) 28017-26', 'Gesser B. (2007) Journal of Investigative Dermatology 27(9) 2129-37']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/dimethyl-fumarate_3.jpg  C6H8O4
['dTAG-13', '/screening-compounds/698625', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/374.jpg', 'C57H68N4O15', '1049.18', 'degrader for FKBP12/f36v']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/374.jpg  C57H68N4O15
['EGCG (Epigallocatechin Gallate)', '/screening-compounds/341056', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/egcg_4.jpg', 'C22H18O11', '458.4', 'PKC', "Dell'Aica I. (2004) EMBO Rep. 5 418-422", 'Tachibana H. (2004) Nat. Struct. Mol. Biol. 11 380']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/egcg_4.jpg  C22H18O11
['EMD638683', '/screening-compounds/617594', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/EMD638683.jpg', 'C18H18F2N', '364.34', 'SGK1', 'Miyayama T (2014) Environ Toxicol Pharmacol 38(2) 374-8']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/EMD638683.jpg  C18H18F2N
['ER-27319', '/screening-compounds/348804', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/er-27319_5.jpg', 'C20H22N2O5', '370.40', 'SYK', 'Moriya K.  (1997) Proc. Natl. Acad. Sci. USA 94  12539-12544']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/er-27319_5.jpg  C20H22N2O5
['ETP 46464', '/screening-compounds/349411', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/etp-46464_6.jpg', 'C30H22N4O2', '470.52', 'ATRi', 'Toledo L.I. (2011) Nature structural and molecular biology 18 721-727']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/etp-46464_6.jpg  C30H22N4O2
['Febuxostat (TMX-67, Adenuric, Uloric)', '/screening-compounds/349394', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/febuxostat_6.jpg', 'C16H16N2O3S', '316.37', 'Xanthine oxidase (XO)', 'Gaffo AL. (2010 ) Core Evid. 4 25-36', 'Grabowski B (2010) Br J Clin Pharmacol.  70 57-64']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/febuxostat_6.jpg  C16H16N2O3S
['FMK (Caspase Inhibitor I)', '/screening-compounds/341057', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/fmk_4.jpg', 'C22H30FN3O7', '467.5', 'Caspase', 'Martin U. (2007) Apoptosis 12 525', 'Misaghi S. (2004) Chem. Biol. 11 1677']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/fmk_4.jpg  C22H30FN3O7
['Fostamatinib', '/screening-compounds/594374', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/Fostamatinib.jpg', 'C23H26FN6O9P', '580.46']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/Fostamatinib.jpg  C23H26FN6O9P
['GDC-0941', '/screening-compounds/341058', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gdc-0941_4.jpg', 'C23H29N7O3S2Cl2', '586.57', 'PI3K', 'Folkes AJ. (2008) J Med Chem. 5522-32']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gdc-0941_4.jpg  C23H29N7O3S2Cl2
['Genentech LRRK2 inhibitor compound 18 (GNE-7915)', '/screening-compounds/351450', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gne-7915_1.jpg', 'C19H21F4N5O3', '443.40', 'LRRK2', 'Estrada AA (2012) J Med Chem 55(22) 9416-33']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gne-7915_1.jpg  C19H21F4N5O3
['Genentech LRRK2 inhibitor compound 19', '/screening-compounds/351451', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/genentech_LRRK2_inhibitor_compound_19_1.jpg', 'C20H21F4N5O3', '455.41', 'LRRK2', 'Estrada AA (2012) J Med Chem 55(22) 9416-33']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/genentech_LRRK2_inhibitor_compound_19_1.jpg  C20H21F4N5O3
['Genistein', '/screening-compounds/341059', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/genistein_4.jpg', 'C15H10O5', '270.2', 'Tyrosine-kinases', 'Constantinou A. and Huberman E. (1995) Proc. Soc. Exp. Biol. Med. 208 109', 'Wei H. (1995) Proc. Soc. Exp. Biol. Med. 208 124']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/genistein_4.jpg  C15H10O5
['GF 109203X (Go 6850)', '/screening-compounds/341060', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gf-109203x_4.jpg', 'C25H24N4O2', '412.5', 'PKC', 'Hers I. (1999) FEBS Lett. 460 433', 'Ku W.-C. (1997) Biochem. Biophys. Res. Commun. 241 730']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gf-109203x_4.jpg  C25H24N4O2
['Gleevec (Imatinib)', '/screening-compounds/341061', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gleevec_3.jpg', 'C29H31N7O', '493.6', 'BCR-ABL, c-KIT, PDGFR', 'Druker B. J. (2000) J. Clin. Invest. 105 3-7']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gleevec_3.jpg  C29H31N7O
['Gö 6976', '/screening-compounds/341062', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/go6976_4.jpg', 'C24H18N4O', '378.4', 'PKC', 'Gschwendt M.  (1996) FEBS Lett. 392 77', 'Wenzel-Seifert K. (1994) Biochem. Biophys. Res. Commun. 200 1536']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/go6976_4.jpg  C24H18N4O
['Gö 7874', '/screening-compounds/341063', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/go7874_3.jpg', 'C27H26N4O4 • HCl', '507', 'PKC', 'Kleinschroth J.  (1995) Bioorg. Med. Chem. Lett. 5 55']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/go7874_3.jpg  C27H26N4O4 • HCl
['GSK2334470', '/screening-compounds/348819', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gsk-2334470a_6.jpg', 'C25H34N8O', '462.59', 'PDK1', 'Najafov A. (2011) Biochem. J. 433 357-69']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gsk-2334470a_6.jpg  C25H34N8O
['GSK2578215A', '/screening-compounds/330902', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gsk2578215a_5.jpg', 'C24H18FN3O2', '399.42', 'LRRK2', 'Reith A. (2012) Bioorg. Med. Chem. Lett.']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gsk2578215a_5.jpg  C24H18FN3O2
['GSK2606414', '/screening-compounds/600854', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/GSK2606414.jpg', 'C24H20F3N5O', '451.44', 'PERK', 'Axten JM. (2012) J. Med. Chem. 23 55(16) 7193-207']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/GSK2606414.jpg  C24H20F3N5O
['GSK269962A', '/screening-compounds/348814', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gsk-269962A_1.jpg', 'C29H30N8O5', '570.61', 'ROCK', 'Doe C. (2007) J Pharmacol Exp Ther 320 89-98']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gsk-269962A_1.jpg  C29H30N8O5
['GSK429286', '/screening-compounds/348813', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gsk429286a_5.jpg', 'C21H16F4N4O2', '432.37', 'ROCK', 'Goodman K. (2007) J. Med. Chem. 50 (1), 6-9', 'Nichols (2009) Biochem.J. 424 47']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gsk429286a_5.jpg  C21H16F4N4O2
['GSK461364', '/screening-compounds/224', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gsk-461364_6.jpg', 'C27H28F3N5O2S', '543.6', 'PLK1', 'T. R. Rheault (2010) Bioorg. Med. Chem. Lett. 20(15) 4587-92', 'K. A. Emmitte (2009) Bioorg. Med. Chem. Lett. 19(6) 1694-7']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gsk-461364_6.jpg  C27H28F3N5O2S
['GSK650394A', '/screening-compounds/348807', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gsk-50394_5.jpg', 'C25H22N2O2', '382.45', 'SGK', 'Sherk A. B. (2008) Cancer Res 68 7475–7483']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gsk-50394_5.jpg  C25H22N2O2
['GW441756 hydrochloride', '/screening-compounds/345908', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gw441756_5.jpg', 'C17H13N3O • HCl', '311.77', 'Trk A', 'Wood E.R. (2004) Bioorg. Med. Chem. Lett. 14 953-957']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gw441756_5.jpg  C17H13N3O • HCl
['GW501516', '/screening-compounds/348798', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gw501516_4.jpg', 'C21H18F3NO3S2', '453.5', 'PPARd', 'Sznaidman M.L. (2003) Bioorg Med Chem Lett 13(9) 1517-21']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gw501516_4.jpg  C21H18F3NO3S2
['GW5074 (Raf1 Kinase Inhibitor I)', '/screening-compounds/341064', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gw5074_4.jpg', 'C15H8Br2INO2', '520.9', 'cRAF1', 'Lackey K.  (2000) Bioorg. Med. Chem. Lett. 10 223']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gw5074_4.jpg  C15H8Br2INO2
['GW843682X (GSK-PLK1 Compound 2)', '/screening-compounds/349409', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gsk-plk1-compound-2_4.jpg', 'C22H18F3N3O4S', '477.46', 'PLK1', 'Emmitte K.A. (2009) Bioorganic and Medicinal Chemistry Letters 19 1018-1021']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/gsk-plk1-compound-2_4.jpg  C22H18F3N3O4S
['H-1152 (Rho Kinase Inhibitor)', '/screening-compounds/341065', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/h1152_4.jpg', 'C16H21N3O2S • 2HCl', '392.3', 'ROCK', 'Ikenoya M.  (2002) J. Neurochem. 81 9', 'Sasaki Y. (2002) Pharmacol. Ther. 93 225']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/h1152_4.jpg  C16H21N3O2S • 2HCl
['H-7, Dihydrochloride', '/screening-compounds/341066', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/h-7_2.jpg', 'C14H17N3O2S • 2HCl', '364.3', 'serine/threonine kinases', 'Ku W.C. (1997) Biochem. Biophys. Res. Commun. 241 730', 'Jarvis W.D. (1994) Cancer Res. 54 1707']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/h-7_2.jpg  C14H17N3O2S • 2HCl
['H-8, Dihydrochloride', '/screening-compounds/341067', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/h-8_4.jpg', 'C12H15N3O2S • 2HCl', '338.3', 'serine/threonine kinases', 'Ido M. (1991) Br. J. Cancer 64 1103', 'Hagiwara M. (1987) Mol. Pharmacol. 31 523']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/h-8_4.jpg  C12H15N3O2S • 2HCl
['H-89, Dihydrochloride', '/screening-compounds/341068', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/h-89_4.jpg', 'C20H20BrN3O2S • 2HCl', '519.3', 'PKA', 'Leemhuis J.  (2002) J. Pharmacol. Exp. Ther. 300 1000', 'Davies S.P. (2000) Biochem. J. 351 95']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/h-89_4.jpg  C20H20BrN3O2S • 2HCl
['HA-1077, Dihydrochloride (Fasudil)', '/screening-compounds/341069', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ha-1077_4.jpg', 'C14H17N3O2S • 2HCl', '364.3', 'PKA', 'Watanabe K. (2007) Nature Biotechnology 25 681', 'Swärd K. (2000) J. Physiol. 522 33']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ha-1077_4.jpg  C14H17N3O2S • 2HCl
['HA-1100 (Hydroxyfasudil)', '/screening-compounds/348808', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ha-1100_5.jpg', 'C14H17N3O3S.HCl', '343.83', 'ROCK', 'S. Wolfrum (2004) Arterioscler. Thromb. Vasc. Biol. 24 1842']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ha-1100_5.jpg  C14H17N3O3S.HCl
['Harmaline', '/screening-compounds/341070', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/harmaline_4.jpg', 'C13H14N2O', '214.263', 'serotonin, monoamine oxidase', 'Herraiz T. (2013) Drug Test. 1002/dta.1530.']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/harmaline_4.jpg  C13H14N2O
['Harmalol', '/screening-compounds/345885', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/harmalol_4.jpg', 'C12H12N2O • HCl • 2H2O', '272.73', 'serotonin, monoamine oxidase', 'Riba J. (2012) Drug Test. 610-6.']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/harmalol_4.jpg  C12H12N2O • HCl • 2H2O
['Harmane', '/screening-compounds/345886', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/harmane_3.jpg', 'C12H10N2', '182.22', 'serotonin, monoamine oxidase', 'Smith KL. (2013) J Psychopharmacol. 162-70']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/harmane_3.jpg  C12H10N2
['Harmine', '/screening-compounds/345887', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/harmine_5.jpg', 'C13H12N2O', '212.25', 'serotonin, monoamine oxidase', 'Song Y. (2004) Biochem. Biophys. Res. Commun. 317 128–132']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/harmine_5.jpg  C13H12N2O
['HG-10-102-01', '/screening-compounds/330903', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/hg-10-102-01_5.jpg', 'LRRK2', 'Choi H.G. (2012) ACS Med. Chem. Lett.']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/hg-10-102-01_5.jpg  LRRK2
['HG-9-91-01', '/screening-compounds/340813', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/hg-9-91-01_1.jpg', 'C32H38ClN7O3', '604.14', 'SIK', 'Clark K. (2012) Proc Natl Acad Sci USA 109(42) 16986-91']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/hg-9-91-01_1.jpg  C32H38ClN7O3
['Hypothemycin', '/screening-compounds/228', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/hypothemycin_6.jpg', 'C19H22O8', '378.37', 'cyclin D1', 'H. Sonoda (1999) Life Sci. 65 381', 'A. Zhao (1999) J. Antibiot. 52 1086']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/hypothemycin_6.jpg  C19H22O8
['IC261', '/screening-compounds/345888', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ic261_5.jpg', 'C18H17NO4', '311.3', 'CK1', 'Behrend L.  (2000) Oncogene 19 5303', 'Mashhoon N. (2000) J. Biol. Chem. 275 20052']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ic261_5.jpg  C18H17NO4
['IKK Inhibitor VII', '/screening-compounds/349376', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ikk-inhibitor-vii_5.jpg', 'C28H29N5OS', '483.6', 'IKK', 'Waelchli R. (2006) Bioorg. Med. Chem. Lett. 16 108']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ikk-inhibitor-vii_5.jpg  C28H29N5OS
['IKK-2 Inhibitor IV (TPCA-1)', '/screening-compounds/345889', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ikk2-inhibitor-iv_4.jpg', 'C12H10FN3O2S', '279.3', 'IKK2', 'Podolin P.L. (2005) J. Pharmacol. Exp. Ther. 312 373', 'Karin M. (2004) Nat. Rev. Drug Discov. 3 17']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ikk2-inhibitor-iv_4.jpg  C12H10FN3O2S
['IKK-2 Inhibitor VIII', '/screening-compounds/349377', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ikk2-inhibitor-viii_4.jpg', 'C21H24N4O2', '364.4', 'IKK2', 'Murata T. (2004) Bioorg. Med. Chem. Lett. 14 4019']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ikk2-inhibitor-viii_4.jpg  C21H24N4O2
['IKK-3 inhibitor IX', '/screening-compounds/345890', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ikk3-inhibitor_3.jpg', 'C22H19N3O5S2', '469.5', 'IKK3', 'Bamborough P. (2006) Bioorg. Med. Chem. Lett. 16 6236']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ikk3-inhibitor_3.jpg  C22H19N3O5S2
['IMD-0354', '/screening-compounds/348826', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/imd-0354_5.jpg', 'C15H8ClF6NO2', '383.67', 'IKK2', 'Tanaka A, (2005) Blood 105 2324-2331']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/imd-0354_5.jpg  C15H8ClF6NO2
['IPA-3', '/screening-compounds/348794', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ipa-3_4.jpg', 'C20H14O2S2', '350.45', 'PAK1', 'Deacon S.W. (2008) Chemistry and Biology 15 322']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ipa-3_4.jpg  C20H14O2S2
['IRAK 1-4 Inhibitor 1', '/screening-compounds/348806', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/irak-1-4-inhibitor-1_5.jpg', 'C20H21N5O4', '395.41', 'IRAK1, IRAK4', 'Powers J. P. (2006) Bioorg. Med. Chem. Lett. 16 2842-2845']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/irak-1-4-inhibitor-1_5.jpg  C20H21N5O4
['IRAK-4 kinase inhibitor a', '/screening-compounds/345891', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/irak-4-inhibitor_3.jpg', 'C22H24N4O6', '440.45', 'IRAK4', 'Wang Z. (2006) Structure 14 1835-1844']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/irak-4-inhibitor_3.jpg  C22H24N4O6
['IRAK-4 kinase inhibitor b', '/screening-compounds/229', 'C22H24N4O6', '440.45', 'IRAK4']
C22H24N4O6  440.45
['Ischemin', '/screening-compounds/349412', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ischemin_6.jpg', 'C15H17N3O4S', '335.38', 'p53 CBP', 'Jagat C. Borah (2011) Chemistry & Biology, 18 4 531-541']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ischemin_6.jpg  C15H17N3O4S
['JNKIN7', '/screening-compounds/225', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/jnkin7_6.jpg', 'C28H27N7O2', '493.56', 'JNK', 'Zhang T. (2012) Chem Biol. 19(1) 140-54']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/jnkin7_6.jpg  C28H27N7O2
['JNKIN8', '/screening-compounds/226', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/jnkin8_5.jpg', 'C29H29N7O2', '507.59', 'JNK', 'Zhang T. (2012) Chem Biol. 19(1) 140-54']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/jnkin8_5.jpg  C29H29N7O2
['K252a', '/screening-compounds/345892', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/k252a_4.jpg', 'C27H21N3O5', '467.5', 'CaMKII', 'Cools J.  (2004) Cancer Res. 64 6385', 'Chin L.S. (1999) Cancer Invest. 17 391']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/k252a_4.jpg  C27H21N3O5
['Kalopanaxsaponin A', '/screening-compounds/589959', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/kalopanaxsaponin-a.jpg', 'C41H66O12', '750.96']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/kalopanaxsaponin-a.jpg  C41H66O12
['Kenpaullone', '/screening-compounds/345893', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/kenpaullone_3.jpg', 'C16H11BrN2O', '327.2', 'GSK, CDK', 'Bain J.  (2003) Biochem. J. 371 199', 'Buolamwini J.K. (2000) Curr. Pharm. Des. 6 379']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/kenpaullone_3.jpg  C16H11BrN2O
['KIN 112', '/screening-compounds/349416', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/kin-112_5.jpg', 'C32H36N6O4', '568.67', 'Lck', 'Martin M.W. (2006)  J.Med.Chem. 49 4981-4991']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/kin-112_5.jpg  C32H36N6O4
['KN62', '/screening-compounds/345895', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/kn62_4.jpg', 'C38H35N5O6S2', '721.9', 'CaMKII', 'Minami H. (1994) Biochem. Biophys. Res. Commun. 199 241']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/kn62_4.jpg  C38H35N5O6S2
['KN93', '/screening-compounds/345896', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/kn-93_3.jpg', 'C26H29CIN2O4S', '501', 'CaMKII', 'Fan G.H.  (1999) Mol. Pharmacol. 56 39', 'Tombes R.M. (1995) Cell Growth Differ. 6 1063']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/kn-93_3.jpg  C26H29CIN2O4S
['KT5720', '/screening-compounds/345897', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/kt5720_4.jpg', 'C32H31N3O5', '537.6', 'PKA', 'Simpson CS. Morris BJ. (1995) Neuroscience 68 97-106', 'Cabell L. Audesirk G. (1993) Int. J. Dev. Neurosci. 11 357']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/kt5720_4.jpg  C32H31N3O5
['KU 0063794', '/screening-compounds/348811', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ku-00637945_5.jpg', 'C25H31N5O4', '465.54', 'mTOR', 'Juan M. García-Martínez (2009) Biochem J. 421 29–42']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ku-00637945_5.jpg  C25H31N5O4
['KU 55933', '/screening-compounds/348820', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ku-55933_5.jpg', 'C21H17NO3S2', '395.49', 'ATM kinase', 'Hickson (2004) Cancer Res. 64 9152']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ku-55933_5.jpg  C21H17NO3S2
['KU55933', '/screening-compounds/600886', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/Ku-55933.jpg', 'C21H17NO3S2', '395.49', 'ATM', 'Li Y. (2010) Mol. Cancer Ther. 2010 Jan. 9(1) 113-25']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/Ku-55933.jpg  C21H17NO3S2
['LDN-193189', '/screening-compounds/349384', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ldn-193189_6.jpg', 'C25H22N6', '406.49', 'BMP', 'Yu (2008) Nat. Chem. Biol. 4 33–41', 'Cuny  (2008) Bioorg. Med. Chem. Lett. 18 4388–4392']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ldn-193189_6.jpg  C25H22N6
['Leflunomide', '/screening-compounds/591457', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/leflunamide.jpg', 'C12H9F3N2O2', '270.20727']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/leflunamide.jpg  C12H9F3N2O2
['Lenalidomide (Revlimid)', '/screening-compounds/340808', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/lenalidomide_2.jpg', 'C13H13N3O3', '259.26', 'TNF-α', 'Rushworth S.A. (2013) Cellular Signalling 25 1 106-112']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/lenalidomide_2.jpg  C13H13N3O3
['LFM-A13', '/screening-compounds/349396', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/lfm-a13_6.jpg', 'C11H8Br2N2O2', '360.0', 'BTK', 'Vassilev J.Biol.Chem. 274 1646', 'Mahajan et al J.Biol.Chem. 274 9587']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/lfm-a13_6.jpg  C11H8Br2N2O2
['LiCl', '/screening-compounds/345898', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/licl_4.jpg', 'ClLi', '42.394', 'GSK3b', 'Galli C. (2013) Clin Oral Implants Res. 921-7.']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/licl_4.jpg  ClLi
['LRRK2-IN1', '/screening-compounds/349386', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/lrrk2-i-1_6.jpg', 'C31H38N8O3', '570.69', 'LRRK2', 'Deng X. (2011) Nat. Chem. Biol. 7 203']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/lrrk2-i-1_6.jpg  C31H38N8O3
['LY294002', '/screening-compounds/345899', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ly294002_5.jpg', 'C19H17NO3', '307.4', 'PI3K', 'Baumann P. and West S.C. (1998) Proc. Natl. Acad. Sci. USA 95 14066', 'Cardone M.H. (1998) Science 282 1318']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ly294002_5.jpg  C19H17NO3
['LY333531 (Ruboxistaurin)', '/screening-compounds/345900', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ly333531_4.jpg', 'C28H28IN4O3 .CH4O3S', '582.73', 'PKC', 'Jirousek M.R. (1996) J. Med. Chem. 39 2664', 'Tang S. (2008) Proteins 72(1) 447-60']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ly333531_4.jpg  C28H28IN4O3 .CH4O3S
['LY364947', '/screening-compounds/349387', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ly364947_6.jpg', 'C17H12N4', '272.31', 'TGF-β type-I', 'Sawyer (2003)  J.Med.Chem. 46 3953', 'Li (2006)  J.Med.Chem. 49 2138']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ly364947_6.jpg  C17H12N4
['Merck 7 (PDK1)', '/screening-compounds/349407', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/merck-7_3.jpg', 'C28H22F2N4O4', '516.5', 'PDK1', 'Nagashima K. (2011) J.Biol.Chem. 286 6433-6448']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/merck-7_3.jpg  C28H22F2N4O4
['Metformin', '/screening-compounds/600890', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/Metformin.jpg', 'C4H11N5', '129.16', 'AMP', 'Ouyang J. (2010) J. Biol. Chem. 2011 Jan. 7 286(1) 1-11']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/Metformin.jpg  C4H11N5
['MK-2206', '/screening-compounds/348829', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/mk-2206_4.jpg', 'C25H21N5O.2HCl', '480.39', 'PKB', 'Hui-Fang Li (2009) Radiation Oncology 4 43']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/mk-2206_4.jpg  C25H21N5O.2HCl
['ML-7, Hydrochloride', '/screening-compounds/345901', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ml-7_5.jpg', 'C15H17IN2O2S • HCl', '452.7', 'MLCK', 'Krarup T. (1998) Am. J. Physiol. 275 C239', 'Saitoh M. (1987) J. Biol. Chem. 262 7796']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ml-7_5.jpg  C15H17IN2O2S • HCl
['ML-9, Hydrochloride', '/screening-compounds/345902', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ml-9_5.jpg', 'C15H17ClN2O2S • HCl', '361.3', 'MLCK', 'Reig J.A.  (1993) Neurochem. Res. 18 317', 'Nagatsu T. (1987) Biochem. Biophys. Res. Commun. 143 1045']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ml-9_5.jpg  C15H17ClN2O2S • HCl
['MLi-2', '/screening-compounds/672622', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/mli-2.jpg', 'C21H25N5O2', 'LRRK2', 'Matthew J. Fell (2015) Journal of Pharmacology and Experimental Therapeutics 355(3) 397-409']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/mli-2.jpg  C21H25N5O2
['MLN120B', '/screening-compounds/348795', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ml120b_4.jpg', 'C19H17Cl3N4O2', '439.72', 'IKKb', 'Nagashima K. Fraser C.C. (2006) Blood 107 4266-4273', 'Catley M.C. Newton R. (2006) Mol.Pharmacol. 70 697-705']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ml120b_4.jpg  C19H17Cl3N4O2
['MLN4924', '/screening-compounds/349375', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/mln4924_2.jpg', 'C21H26ClN5O4S', '479.98', 'NEDD8-activating enzyme', 'Teresa A. Soucy (2009) Nature 458 732-736']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/mln4924_2.jpg  C21H26ClN5O4S
['MLN9708', '/screening-compounds/349382', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/mln9708_5.jpg', 'C20H23BCl2N2O9', '517.12', 'Proteasome', 'Kupperman. E. (2010) Cancer Research 70 1970-1980']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/mln9708_5.jpg  C20H23BCl2N2O9
['MRT199665', '/screening-compounds/591442', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/mrt-199665.jpg', 'C28H31N5O2.ClH', '506.04', 'MARK', 'Clark K. (2012) Proc Natl Acad Sci USA 109(42) 16986-91']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/mrt-199665.jpg  C28H31N5O2.ClH
['MRT67307', '/screening-compounds/349395', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/mrt67307_6.jpg', 'C26H36N6O2', '464.60', 'IKKε, TBK1', 'Clark K. (2011) Biochem. J. 434 93-104']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/mrt67307_6.jpg  C26H36N6O2
['MSC 2032964A', '/screening-compounds/349400', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/msc-2032964a_5.jpg', 'C16H13F3N6O', '362.31', 'ASK1', 'Guo X. (2010) EMBO Molecular Medicine 2 504-515']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/msc-2032964a_5.jpg  C16H13F3N6O
['Necrostatin-1 (Nec-1)', '/screening-compounds/345904', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/nec-1_5.jpg', 'C13H13N3OS', '259.33', 'RIP', 'Degterev A. Hitomi J. (2008) Nature Chemical Biology 4 313-321']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/nec-1_5.jpg  C13H13N3OS
['Nectrostatin-1 (Nec-1 inactive analog)', '/screening-compounds/345905', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/nec-1-inactive_5.jpg', 'C12H11N3OS', '245.3', 'RIP', 'Degterev A. Hitomi J. (2008) Nature Chemical Biology 4 313-321']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/nec-1-inactive_5.jpg  C12H11N3OS
['NG-25', '/screening-compounds/340160', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ng-25_2.jpg', 'C29H30F3N5O2', '537.58', 'TAK1', 'Dzamko N (2012) PLoS ONE 7(6) e39132 10 1371', 'Eduardo Pauls (2012) Journal of Biological Chemistry 287 23 19216-19228']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ng-25_2.jpg  C29H30F3N5O2
['NIK SMI1 (+)  dextrorotatory', '/screening-compounds/698627', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/376.jpg', 'C20H19N3O4', '365.39', 'NIK inhibitor']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/376.jpg  C20H19N3O4
['NIK SMI1 (-)  levorotatory', '/screening-compounds/698626', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/375.jpg', 'C20H19N3O4', '365.39', 'NIK inhibitor']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/375.jpg  C20H19N3O4
['NIK-Novartis-T1-7', '/screening-compounds/674400', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/NIK-Novartis-T1-7.png', 'C18H14N6OS', '362.41', 'NIK']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/NIK-Novartis-T1-7.png  C18H14N6OS
['Novartis 12a (PKD1)', '/screening-compounds/349408', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/novartis-12a_4.jpg', 'C23H29F3N6O3', '494.51', 'PKD1', 'Meredith E.L. (2010) J.Med.Chem. 53 5422-5438']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/novartis-12a_4.jpg  C23H29F3N6O3
['NVP-BEZ 235', '/screening-compounds/345906', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/nvp-bez-235_5.jpg', 'C30H25Cl2N5O', '542.46', 'PI3K, Akt, mTOR', 'Maira S. Stauffer F. (2008) Mol. Cancer. Ther. 7 1851-1863.']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/nvp-bez-235_5.jpg  C30H25Cl2N5O
['OSU-03012', '/screening-compounds/334627', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/osu-03012_4.jpg', 'C26H19F3N4O', '460.45', 'PDK1', 'Zhu J. (2004) Cancer Res. 64(12) 4309-18']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/osu-03012_4.jpg  C26H19F3N4O
['OTSSP167', '/screening-compounds/594372', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/OTSSP167.jpg', 'C25H28Cl2N4O2', '487.42', 'MELK']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/OTSSP167.jpg  C25H28Cl2N4O2
['Parthenolide', '/screening-compounds/340810', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/parthenolide_2.jpg', 'C15H20O3', '248.32', 'IKKβ', 'Kwok B.H. (2001) Chem. Biol. 8 759-766']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/parthenolide_2.jpg  C15H20O3
['PCI-32765 (Ibrutinib)', '/screening-compounds/349403', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pci-32765_5.jpg', 'C25H24N6O2', '440.5', 'Btk', 'Honigberg L.A. (2010) Proc Natl Acad Sci 107 13075-13080']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pci-32765_5.jpg  C25H24N6O2
['PD 0325901', '/screening-compounds/349399', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pd-0325901_6.jpg', 'C16H14F3IN2O4', '482.19', 'MEK1', 'Bain J. (2007) Biochem J. 408 297–315.', 'Barrett SD. (2008) Bioorg. Med. Chem. Lett. 18 6501-6504.']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pd-0325901_6.jpg  C16H14F3IN2O4
['PD 0325901-Cl (CI-1055-R)', '/screening-compounds/349405', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pd-0325901cl_11.jpg', 'C16H14O4N2F2ClI', '498.65', 'MEK1']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pd-0325901cl_11.jpg  C16H14O4N2F2ClI
['PD 0325901-Cl (CI-1055-Racemic mix of isomers)', '/screening-compounds/349406', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pd-0325901cl_0.jpg', 'C16H14O4N2F2ClI', '498.65', 'MEK1']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pd-0325901cl_0.jpg  C16H14O4N2F2ClI
['PD 0325901-Cl (CI-1055-S)', '/screening-compounds/345907', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pd-0325901cl_12.jpg', 'C16H14O4N2F2ClI', '498.65', 'MEK1']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pd-0325901cl_12.jpg  C16H14O4N2F2ClI
['PD 0332991', '/screening-compounds/348821', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pd-0332991_5.jpg', 'C24H30ClN7O2', '483.99', 'CDK4, CDK6', 'Toogood P.L. (2005) J.Med.Chem. 48 2388-2406.']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pd-0332991_5.jpg  C24H30ClN7O2
['PD 184352 (CI-1040)', '/screening-compounds/345909', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pd-184352_5.jpg', 'C17H14ClF2IN2O2', '478.66', 'MEK1, Yes1, ERK1', 'Mayes PA. (2013) Int J Cancer. E149-57']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pd-184352_5.jpg  C17H14ClF2IN2O2
['PF3644022', '/screening-compounds/330904', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pf3644022_5.jpg', 'C21H18N4OS', '374.46', 'MAPKAPK2', 'Mourey (2010) J.Pharmacol.Exp.Ther. 333 797']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pf3644022_5.jpg  C21H18N4OS
['PF4708671', '/screening-compounds/330906', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pf4708671_4.jpg', 'C19H21F3N6', '390.41', 'S6K1', 'Pearce (2010) Biochem.J. 431 245']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pf4708671_4.jpg  C19H21F3N6
['PI-103', '/screening-compounds/345910', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pi-103_5.jpg', 'C19H16N4O3', '348.36', 'PI3K', 'Samuels Y. (2004) Science 304 554']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pi-103_5.jpg  C19H16N4O3
['Piceatannol', '/screening-compounds/345911', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/piceatannol_5.jpg', 'C14H12O4', '244.2', 'PKA, SYK', 'Wang B.H.  (1998) Planta Med. 64 195', 'Keely P.J. and Parise L.V. (1996) J. Biol. Chem. 271 26668']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/piceatannol_5.jpg  C14H12O4
['Pirfenidone', '/screening-compounds/345912', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pirfenidone_2.jpg', 'C12H11NO', '185.23', 'Antifibrotic agent, SAPK', 'Kehrer and Margolin (1997) Toxicol. Lett. 90 125', 'Iyer  (1999)  J.Pharmacol.Exp.Ther. 289 211']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pirfenidone_2.jpg  C12H11NO
['PKR Inhibitor', '/screening-compounds/589961', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pkr-inhibitor.jpg', 'C13H8N4OS', '268.3', 'PKR', 'Ingrand S (2007) FEBS Lett. 581(23):4473-8']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pkr-inhibitor.jpg  C13H8N4OS
['PLX 4032 (Vemurafenib)', '/screening-compounds/349414', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/plx-4032_5.jpg', 'C23H18ClF2N3O3S', '489.92', 'B-RAF', 'Bollag G. (2010) Nature 467 596-9']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/plx-4032_5.jpg  C23H18ClF2N3O3S
['PLX 4720 (Raf Kinase Inhibitor V)', '/screening-compounds/345913', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/plx-4720_5.jpg', 'C17H14ClF2N3O3S', '413.83', 'B-Raf', 'Tsai J. (2008) Proc Natl Acad Sci USA. 3041-6']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/plx-4720_5.jpg  C17H14ClF2N3O3S
['PP1', '/screening-compounds/345914', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pp1_5.jpg', 'C16H19N5', '281.36', 'Src', 'Hanke (1996) J.Biol.Chem. 271 695', 'Liu  (1999) Chem.Biol. 6 671']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pp1_5.jpg  C16H19N5
['PP2', '/screening-compounds/345915', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pp2_5.jpg', 'C15H16ClN5', '301.77', 'Src', 'Kirihara T. (2013) Exp Eye Res. S0014']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pp2_5.jpg  C15H16ClN5
['PP242', '/screening-compounds/348810', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pp242_5.jpg', 'C16H16N6O', '308.3', 'mTOR', 'Feldman ME (2009) PLoS Biol 7(2)']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pp242_5.jpg  C16H16N6O
['PP3', '/screening-compounds/348818', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pp3_3.jpg', 'C11H9N5', '211.22', 'Src', 'Hou (2007)  Neurosci Lett 420 235']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pp3_3.jpg  C11H9N5
["Princeton's TrkA inhibitor compound 20h", '/screening-compounds/345916', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/princetons-trka_5.jpg', 'C24H24BrF3N6O4S2', '661.52', 'Trk A', 'Kim S.H. Tokarski J.S. (2008) Bioorg. Med. Chem. Lett. 18 634-639']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/princetons-trka_5.jpg  C24H24BrF3N6O4S2
['PRT062607', '/screening-compounds/600887', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/prt062607.jpg', 'C19H23N9O', '393.45', 'SYK', 'Spurgeon S.E. (2013) J. Pharmacol Exp Ther. 2013 Feb. 344(2) 378-387']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/prt062607.jpg  C19H23N9O
['PS-1145', '/screening-compounds/345917', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ps-1145_5.jpg', 'C17H11ClN4O', '322.75', 'IKK', 'Castro A.C. (2003) Bioorg. Med. Chem. Lett. 13 2419-2422.']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ps-1145_5.jpg  C17H11ClN4O
['Purvalanol A', '/screening-compounds/345918', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/purvalanol-a_5.jpg', 'C19H25ClN6O', '388.9', 'cyclin-dependent kinases', 'Gray N.S. (1998) Science 281 533']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/purvalanol-a_5.jpg  C19H25ClN6O
['Purvalanol B', '/screening-compounds/348828', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/purvalanol-b_4.jpg', 'C20H25ClN6O3', '432.9', 'CDK']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/purvalanol-b_4.jpg  C20H25ClN6O3
['QNZ', '/screening-compounds/608462', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/qnz.jpg', 'C22H20N4O', '356.4', 'NF-κB']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/qnz.jpg  C22H20N4O
['Quercetagetin', '/screening-compounds/348817', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/quercetagetin_3.jpg', 'C15H10O8', '318.3', 'PIM1', 'Holder S. (2007) Mol. Cancer Ther. 6 163']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/quercetagetin_3.jpg  C15H10O8
['R-406', '/screening-compounds/349379', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/r406_4.jpg', 'C23H24FN5O5', '469.46', 'SYK', 'Braselmann S. (2006) J Pharmacol Exp Ther. 319(3) 998-1008']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/r406_4.jpg  C23H24FN5O5
['Resveratrol', '/screening-compounds/345920', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/resveratrol_5.jpg', 'C14H12O3', '228.2', 'cyclo-oxygenase 1', 'Lin H.Y.  (2002) J. Urol. 168 748', 'Klabunde T. (2000) Nat. Struct. Biol. 7 312']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/resveratrol_5.jpg  C14H12O3
['Rigel TRAF6 Inhibitor', '/screening-compounds/349378', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/rigel-traf_4.jpg', 'C16H12ClF4N5O3S', '465.81', 'TRAF6']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/rigel-traf_4.jpg  C16H12ClF4N5O3S
['RO-31-8220', '/screening-compounds/345921', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ro-31-8220_5.jpg', 'C25H23N5O2S • CH4O3S', '553.7', 'PKC', 'Trapp J. (2006) J. Med. Chem. 49 7307-16', 'Powell D.J. (2003) Mol. Cell Biol. 23 7794']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ro-31-8220_5.jpg  C25H23N5O2S • CH4O3S
['RO-3306', '/screening-compounds/608458', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/RO-3306.jpg', 'C₁₈H₁₃N₃OS₂', '351.5', 'Cdk1', 'Vassilev, L.T. (2006) Proc. Natl. Acad. Sci. USA 103 10660']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/RO-3306.jpg  C₁₈H₁₃N₃OS₂
['Roscovitine', '/screening-compounds/345922', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/roscovitine_5.jpg', 'C19H26N6O', '354.5', 'CDK', 'De Azevedo W.F. (1997) Eur. J. Biochem. 243 518', 'Meijer L. (1997) Eur. J. Biochem. 243 527']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/roscovitine_5.jpg  C19H26N6O
['Rottlerin', '/screening-compounds/345923', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/rottlerin_5.jpg', 'C30H28O8', '516.5', 'PKC', 'Villalba M. (1999) J. Immunol. 163 5813', 'Gschwendt M. (1994) Biochem. Biophys. Res. Commun. 199 93']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/rottlerin_5.jpg  C30H28O8
['Ruxolitinib (INCB18424)', '/screening-compounds/349392', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ruxolitinib_7.jpg', 'C17H18N6', '306.37', 'JAKs', 'Lawrence J Wilson (2010)  Expert Opinion on Therapeutic Patents May 20(5) 609-623']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ruxolitinib_7.jpg  C17H18N6
['Saracatinib (AZD0530)', '/screening-compounds/340805', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/azd0530_1.jpg', 'C27H32ClN5O5', '542.03', 'Src', 'H Laurent (2006) J. Med. Chem. 49(22) 6465-6488']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/azd0530_1.jpg  C27H32ClN5O5
['SB-202190', '/screening-compounds/345924', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sb202190_3.jpg', 'C20H14FN3O', '331.3', 'p38 MAPK', 'Davies S.P. (2000) Biochem. J. 351 95', 'Ajizian S.J. (1999) J. Infect. Dis. 179 939']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sb202190_3.jpg  C20H14FN3O
['SB-203580', '/screening-compounds/345925', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sb203580_5.jpg', 'C21H16N3OSF', '377.4', 'p38 MAPK', 'Powell D.J. (2003) Mol. Cell Biol. 23 7794', 'Davies S.P. (2000) Biochem. J. 351 95']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sb203580_5.jpg  C21H16N3OSF
['SB-216763', '/screening-compounds/345926', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sb216763_5.jpg', 'C19H12Cl2N2O2', '371.22', 'GSK3', 'Coghlan (2000) Chem.Biol. 7 793', 'Liang (2006) J.Biol.Chem. 282 3904']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sb216763_5.jpg  C19H12Cl2N2O2
['SB-415286', '/screening-compounds/345927', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sb415286_5.jpg', 'C16H10ClN3O5', '359.73', 'GSK3', 'Coghlan (2000) Chem.Biol. 7 793', 'Cross (2001) J.Neurochem. 77 94']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sb415286_5.jpg  C16H10ClN3O5
['SB-431542', '/screening-compounds/348822', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sb-431542_5.jpg', 'C22H16N4O3 · xH2O', '384.39', 'ALK', 'Inman et al (2002) Mol.Pharmacol. 62 65']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sb-431542_5.jpg  C22H16N4O3 · xH2O
['SB-505124', '/screening-compounds/349391', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sb-505124_5.jpg', 'C20H21N3O2 · xHCl · yH2O', '335.40', 'ALK', 'Byfield (2004) Mol.Pharmacol. 65 744']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sb-505124_5.jpg  C20H21N3O2 · xHCl · yH2O
['SB-590885', '/screening-compounds/333184', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sb-590885_0.jpg', 'C27H27N5O2', '453.54', 'B-Raf', 'King (2006) Cancer Res. 66 11100']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sb-590885_0.jpg  C27H27N5O2
['SB-747651A', '/screening-compounds/333185', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sb-747651a.jpg', 'C16H22N8O', '342.40', 'Naqvi (2012) Biochem. J. 441 (347–357)']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sb-747651a.jpg  C16H22N8O
['SC514 ( IKK-2 Inhibitor)', '/screening-compounds/345928', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sc514_5.jpg', 'C9H8N2OS2', '224.3', 'IKK2', 'Baxter A. (2004) Bioorg. Med. Chem. Lett. 14 2817', 'Kishore N. (2003) J. Biol. Chem. 278 32861']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sc514_5.jpg  C9H8N2OS2
['SGK-Sanofi-14i', '/screening-compounds/612327', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/SGK1-Sanofi-14i.jpg', 'C18H15ClN6O3S', '430,.87', 'SGK', 'Halland, N (2015) ACS Medicinal Chemistry Letters  6 73-78']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/SGK1-Sanofi-14i.jpg  C18H15ClN6O3S
['SGK1-Sanofi-14g', '/screening-compounds/612325', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/SGK1-Sanofi--14g.jpg', 'C17H12Cl2N6O2S', '435.29', 'SGK', 'Halland, N (2015) ACS Medicinal Chemistry Letters  6 73-78']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/SGK1-Sanofi--14g.jpg  C17H12Cl2N6O2S
['SGK1-Sanofi-14h', '/screening-compounds/615491', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/SGK1-Sanofi-14h_0.jpg', 'C17H12Cl2N6O2S', '435.29', 'SGK', 'Halland, N (2015) ACS Medicinal Chemistry Letters , 6,73-78']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/SGK1-Sanofi-14h_0.jpg  C17H12Cl2N6O2S
['SGK1-Sanofi-14n', '/screening-compounds/612330', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/SGK1-Sanofi--14n.jpg', 'C17H12CIFN6O2S', '418.83', 'SGK', 'Halland, N (2015) ACS Medicinal Chemistry Letters  6 73-78']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/SGK1-Sanofi--14n.jpg  C17H12CIFN6O2S
['SGK1-Sanofi-308-R', '/screening-compounds/674398', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/SGK1-Sanofi-308R.png', 'C23H23FN6O4S', '498.53', 'SGK1']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/SGK1-Sanofi-308R.png  C23H23FN6O4S
['SGK1-Sanofi-308-S', '/screening-compounds/674399', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/SGK1-Sanofi-308S.png', 'C23H23FN6O4S', '498.53', 'SGK1']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/SGK1-Sanofi-308S.png  C23H23FN6O4S
['SGK1-Sanofi-ex.290-R', '/screening-compounds/674404', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/SGK1-Sanofi-ex.290-R.png', 'C24H25ClN6O5S', '545.01', 'SGK1']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/SGK1-Sanofi-ex.290-R.png  C24H25ClN6O5S
['SGK1-Sanofi-ex.290-S', '/screening-compounds/674401', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/SGK1-Sanofi-ex.290-S.png', 'C24H25ClN6O5S', '545.01', 'SGK1']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/SGK1-Sanofi-ex.290-S.png  C24H25ClN6O5S
['Sirolimus', '/screening-compounds/345919', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/rapamycin_5.jpg', 'C51H79NO13', '914.2', 'p70S6K, mTOR', 'Powell D.J.  (2003) Mol. Cell Biol. 23 7794', 'Braun W. (1995) FASEB J. 9 63']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/rapamycin_5.jpg  C51H79NO13
['SL-327 (MEK1-2 Inhibitor)', '/screening-compounds/345930', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sl-327_5.jpg', 'C16H12F3N3S', '335.4', 'MEK1, MEK2', 'Hetman M. (2002) J. Biol. Chem. 277 49577', 'Ohno M. (2001) Nat. Neurosci. 4 1238']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sl-327_5.jpg  C16H12F3N3S
['SL0101-1', '/screening-compounds/345929', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sl0101-1_5.jpg', 'C25H24O12', '516.46', 'RSK', 'Smith (2005) Cancer Res. 65 1027', 'Goden Sayeski (2006) Am. J. Cell. Physiol. 291 1308']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sl0101-1_5.jpg  C25H24O12
['Sodium salicylate', '/screening-compounds/349388', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/salicylate_6.jpg', 'HOC6H4COONa', '160.10', 'p38', 'Schwenger P. (1998) Mol Cell Biol. Jan 18(1) 78-84']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/salicylate_6.jpg  HOC6H4COONa
['Sodium valproate', '/screening-compounds/345931', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sodium-valproate_5.jpg', 'C8H15NaO2', '166.19', 'Histone deacetylase', 'Phiel (2001) J.Biol.Chem. 276 36734', 'Kostrouchova  (2007) Folia Biologica 53 37']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sodium-valproate_5.jpg  C8H15NaO2
['SP600125 (JNK Inhibitor II,  SAPK Inhibitor II)', '/screening-compounds/345932', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sp600125_5.jpg', 'C14H8N2O', '220.2', 'JNK', 'Shin M. Boyd Y.D. (2002) Biochim. Biophys. Acta 1589 311', 'Bennett B.L. (2001) Proc. Natl. Acad. Sci. USA 98 13681']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sp600125_5.jpg  C14H8N2O
['Sphingosine Kinase Inhibitor (SKI II)', '/screening-compounds/349383', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ski-ii_6.jpg', 'C15H11ClN2OS', '339.2', 'SphK1', 'French (2003) Cancer Res. 63 5962.', 'French (2006) J.Pharmacol.Exp.Ther. 318 596']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ski-ii_6.jpg  C15H11ClN2OS
['SRC Inhibitor 1', '/screening-compounds/345933', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/src-inhibitor-1_5.jpg', 'C22H19N3O3', '373.4', 'Src', 'Tian G. (2001) Biochemistry 40 7084']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/src-inhibitor-1_5.jpg  C22H19N3O3
['SRT 1720', '/screening-compounds/345934', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/srt-1720_5.jpg', 'C27H24F3N7O3S', '583.59', 'SIRT1', 'Milne J.C. Lambert P.D. Schenk S. (2007) Nature 450 712-716']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/srt-1720_5.jpg  C27H24F3N7O3S
['Staurosporine', '/screening-compounds/349401', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/staurosporine_5.jpg', 'C28H26N4O3', '466.54', 'Broad spectrum', 'Boix J. (1997) Neuropharmacology 36  811-821', 'Wiesner D.A. and Dawson G. (1996)  J. Neurochem. 66  1418-1425']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/staurosporine_5.jpg  C28H26N4O3
['STO 609', '/screening-compounds/348780', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sto-609_5.jpg', 'C19H10N2O3 • CH3CO2H', '374.4', 'CaMKK', 'Levine Y. (2007) J. Biol. Chem. 282 20351', 'Tokumitsu H. (2003) J. Biol. Chem. 278 10908']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sto-609_5.jpg  C19H10N2O3 • CH3CO2H
['STOCK1S-50699', '/screening-compounds/600050', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/STOCK1S-50699_0.jpg', 'C29H31IN2S2', '598.60', 'WNK', 'Mori T. (2013) Biochem J. 1 455(3) 339-45']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/STOCK1S-50699_0.jpg  C29H31IN2S2
['STOCK2S-26016', '/screening-compounds/600049', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/stock2s-26016.jpg', 'C20H19N3O2', '333.38976', 'WNK', 'Mori T. (2013) Biochem J. 1 455(3) 339-45']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/stock2s-26016.jpg  C20H19N3O2
['SU-5416 (VEGFR2 Kinase Inhibitor III)', '/screening-compounds/348781', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/su-5416_5.jpg', 'C15H14N2O', '238.3', 'VEGF-R', 'Tille J.C. (2003) Exp. Cell Res. 285 286', 'Itokawa T. (2002) Mol. Cancer Ther. 1 295']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/su-5416_5.jpg  C15H14N2O
['SU-6656', '/screening-compounds/348782', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/su-6656_0.jpg', 'C19H21N3O3S', '371.5', 'Src', 'Bowman T. (2001) Proc. Natl. Acad. Sci. USA 98 7319', 'Blake R.A. (2000) Mol. Cell. Biol. 20 9018']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/su-6656_0.jpg  C19H21N3O3S
['SU-6668', '/screening-compounds/348783', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/su-6668_4.jpg', 'C18H18N2O3', '310.35', 'Aurora', 'Godl K. (2005) Cancer Res. 65 6919-6926.']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/su-6668_4.jpg  C18H18N2O3
['Sulfasalazine', '/screening-compounds/348816', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sulfasalazine_4.jpg', 'C18H14N4O5S', '398.39', 'glutathione-S-transferase', 'Liptay S. (1999) Br. J. Pharmacol. 128 1361', 'Volin M.V. (1999) Arthritis Rheum. 42 1927']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sulfasalazine_4.jpg  C18H14N4O5S
['Sunitinib (SU-11248)', '/screening-compounds/348812', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sunitinib_5.jpg', 'C22H27FN4O2', '398.47', 'RTK, Multiple Tyrosine Kinases Targeted', 'Sakamoto K. M. (2004) Curr Opin Investig Drugs  5(12) 1329-39']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/sunitinib_5.jpg  C22H27FN4O2
['SYK Inhibitor I', '/screening-compounds/348800', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/syk_inhibitor_i_3.jpg', 'C18H15N3O3S', '353.4', 'SYK', 'Lai J.Y. (2003) Bioorg. Med. Chem. Lett. 13 3111']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/syk_inhibitor_i_3.jpg  C18H15N3O3S
['SYK Inhibitor II', '/screening-compounds/348801', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/syk_inhibitor_ii_5.jpg', 'C14H15F3N6O • 2HCl•2H2O', '449.3', 'SYK', 'Hisamichi H. (2005) Bioorg. Med. Chem. 13 4936']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/syk_inhibitor_ii_5.jpg  C14H15F3N6O • 2HCl•2H2O
['SYK Inhibitor III', '/screening-compounds/348802', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/syk_inhibitor_iii_5.jpg', 'C9H7NO4', '193.2', 'SYK', 'Wang W.Y. (2006) Mol. Pharmacol. 70 1380']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/syk_inhibitor_iii_5.jpg  C9H7NO4
['SYK Inhibitor IV (BAY 61-3606)', '/screening-compounds/348803', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/syk_inhibitor_iv_5.jpg', 'C20H18N6O3 • HCl • H2O', '444.9', 'SYK', 'Yamamoto N. (2003) J Pharmacol Exp Ther 306 1174']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/syk_inhibitor_iv_5.jpg  C20H18N6O3 • HCl • H2O
['TAE684', '/screening-compounds/330901', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/tae684_5.jpg', 'C30H40ClN7O3S', '614.22', 'NPM-ALK', 'Zhang J. (2012) Bioorg. Med. Chem. Lett. 22 1864–1869', 'Galkin A.V. (2007) Proc. Natl. Acad. Sci. USA  104 (1) 270-275']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/tae684_5.jpg  C30H40ClN7O3S
['Tenovin-6', '/screening-compounds/594375', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/tenovin-6.jpg', 'C25H34N4O2S', '454.6']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/tenovin-6.jpg  C25H34N4O2S
['TG003', '/screening-compounds/348827', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/tg003_5.jpg', 'C13H15NO2S', '249.33', 'Cdc2-like kinase', 'Muraki M. (2004) J. Biol. Chem. 279 24246-24254']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/tg003_5.jpg  C13H15NO2S
['Torin1', '/screening-compounds/330905', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/torin_4.jpg', 'C35H28F3N5O2', '607.62', 'mTOR', 'Liu Q. (2012) J Biol Chem. 287 9742-52']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/torin_4.jpg  C35H28F3N5O2
['TTT-3002', '/screening-compounds/340814', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ttt-3002_2.jpg', 'LRRK2', 'Yao C (2012) Hum Mol Genet.']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ttt-3002_2.jpg  LRRK2
['Ubiquitin E1 Inhibitor (PYR-41)', '/screening-compounds/349398', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pyr-41_6.jpg', 'C17H13N3O7 • 3H2O', '425.4', 'Ubiquitin-E1', 'Yang Y (2007) Cancer Res. 67 9472']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/pyr-41_6.jpg  C17H13N3O7 • 3H2O
['UCN-01', '/screening-compounds/348784', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ucn-01_4.jpg', 'C28H26N4O4', '482.5', 'PKC', 'Reinhardt H.C. (2007) Cancer Cell 11 175', 'Jiang X. (2004) Mol. Cancer Ther. 3 1221']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/ucn-01_4.jpg  C28H26N4O4
['Uo126', '/screening-compounds/348785', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/uo126_4.jpg', 'C18H16N6S2', '380.48', 'MEK1, MEK2', 'Favata (1998) J. Biol. Chem. 273 18623', 'Duncia  (1998) Bioorg. Med. Chem. Lett. 8 2839']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/uo126_4.jpg  C18H16N6S2
['Volasertib', '/screening-compounds/608460', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/volasertib.jpg', 'C34H50N8O3', '618.81', 'PLK1', 'Rudolph D (2009) Clin Cancer Res 15(9) 3094-3102', 'Grinshtein N (2011) Cancer Res 71(4) 1385-1395']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/volasertib.jpg  C34H50N8O3
['VPS34-IN1', '/screening-compounds/606437', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/AZ-1194.jpg', 'C21H24ClN7O', '425.91', 'Vps34', 'Bago R (2014) Biochem J.']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/AZ-1194.jpg  C21H24ClN7O
['VPS34-IN2 (PIK-III)', '/screening-compounds/600889', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/VPS34-IN2_0.jpg', 'C17H17N7', '319.36', 'PI3K,  VPS34', 'William E. Dowdle (2014) Nature Cell Biology']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/VPS34-IN2_0.jpg  C17H17N7
['VX-680', '/screening-compounds/348787', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/vx-680_4.jpg', 'C23H28N8OS', '464.59', 'Aurora', 'Harrington E.A. (2004) Nature Medicine 10 262']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/vx-680_4.jpg  C23H28N8OS
['VX-745', '/screening-compounds/348786', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/vx-475_4.jpg', 'C19H9Cl2F2N3OS', '436.26', 'p38 MAPK', 'Tsai YR Epub 2013 Jan 21 Eur J Pharmacol.  2013 Feb 15 701(1-3) 96-105']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/vx-475_4.jpg  C19H9Cl2F2N3OS
['Withaferin A', '/screening-compounds/340809', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/withaferin-a_2.jpg', 'C28H38O6', '470.6', 'IKKβ', 'Kaileh (2007) J.Biol.Chem. 282 4253']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/withaferin-a_2.jpg  C28H38O6
['WNK-463', '/screening-compounds/680023', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/wnk-463.png', 'C21H24F3N7O2', '463.46', 'WNK', 'Yamada K (2016) Nat Chem Biol. 12(11) 896-898']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/wnk-463.png  C21H24F3N7O2
['Wortmannin (KY 12420)', '/screening-compounds/348788', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/wortmannin_5.jpg', 'C23H24O8', '428.4', 'PI3K', 'Cross M.J. (1995) J. Biol. Chem. 270 25352', 'Nakamura I. (1995) FEBS Lett. 361 79']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/wortmannin_5.jpg  C23H24O8
['WP1130', '/screening-compounds/591459', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/WP1130.jpg', 'C19H18BrN3O', '384.26972', 'DUB', 'V Kapuria (2011) Cell Signal 23(12) 2076-2085.', 'V Kapuria (2010) Cancer Res 70(22) 9265-9276']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/WP1130.jpg  C19H18BrN3O
['Wyeth PDK1 Inhibitor Compound 1', '/screening-compounds/348789', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/wyeth-pdk-1_5.jpg', 'C19H22Cl4N4O2', '480.21', 'PDK1', 'Gopalsamy A. (2007) Journal of Medicinal Chemistry  50 (23)  5547-5549']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/wyeth-pdk-1_5.jpg  C19H22Cl4N4O2
['Y-27632', '/screening-compounds/348790', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/y-27632_4.jpg', 'C14H21N3O • 2HCl • H2O', '338.3', 'ROCK', 'Watanabe K. (2007) Nature Biotech. 25 681', 'Chitaley K. (2001) Nat. Med. 7 119']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/y-27632_4.jpg  C14H21N3O • 2HCl • H2O
['Zearalenone', '/screening-compounds/348791', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/zearalenone_5.jpg', 'C18H22O5', '318.4', 'Estrogen receptor (ER)', 'Powell-Jones W. (1981) Mol. Pharmacol. 20 35-42']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/zearalenone_5.jpg  C18H22O5
['ZM 336372', '/screening-compounds/348792', 'https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/zm-336372_4.jpg', 'C23H23N3O3', '389.4', 'c-Raf', 'Hall-Jackson C.A. (1999) Chem. Biol. 6 559']
https://www.kinase-screen.mrc.ac.uk/system/files/compounds/jpg/zm-336372_4.jpg  C23H23N3O3